Optimization of Extended-Release Tacrolimus Dose with Mycophenolate Mofetil based Immunosuppression in De novo Kidney Transplant Recipients using extensive pharmacokinetics monitoring
Phase 3
- Conditions
- End Stage Renal Disease patients to whom kidney transplantation is planned
- Registration Number
- JPRN-UMIN000033089
- Lead Sponsor
- Department of Transplant Surgery Kidney Disease Center Nagoya Daini Red Cross Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) Multiple organ recipient or previous transplant history. 2) HLA identical living related donor. 3) ABO incompatible or T cell CDC-crossmatch positive case. 4) HIV, HCV, HBsAb positive recipients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method